Riba J

Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Universiteitssingel 40, Maastricht, 6229 ER, The Netherlands.

18 papers · ORCID

ArticleDMT

Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.

Uthaug MV, Lancelotta R, Szabo A +3

Europe PMC2026
ArticleAyahuasca

Personality, not cognition, distinguishes chronic ayahuasca and cannabis users from non-users.

Bouso JC, Andión O, Estévez SF +6

Europe PMC2026
ArticleAyahuasca

Preliminary evidence of links between ayahuasca use and the corpus callosum.

Simonsson O, Bouso JC, Kurth F +4

Europe PMC2022
ArticlePsychedelics

The Kappa Opioid Receptor and the Sleep of Reason: Cortico-Subcortical Imbalance Following Salvinorin-A.

Ona G, Sampedro F, Romero S +10

Europe PMC2022
ArticleAyahuasca

A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.

Uthaug MV, Mason NL, Toennes SW +6

Europe PMC2021
ArticleAyahuasca

N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo.

Morales-Garcia JA, Calleja-Conde J, Lopez-Moreno JA +4

Europe PMC2020
ArticleDMT

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.

Uthaug MV, Lancelotta R, Szabo A +3

Europe PMC2020
ArticleDMT

A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.

Uthaug MV, Lancelotta R, van Oorsouw K +10

Europe PMC2019
ArticleAyahuasca

Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution.

Uthaug MV, van Oorsouw K, Kuypers KPC +6

Europe PMC2018
ArticleAyahuasca

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.

Palhano-Fontes F, Barreto D, Onias H +20

Europe PMC2019
ArticleAyahuasca

Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program.

Soler J, Elices M, Dominguez-Clavé E +5

Europe PMC2018
ArticleAyahuasca

New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca.

McKenna D, Riba J

Europe PMC2018
ArticleAyahuasca

Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.

Sampedro F, de la Fuente Revenga M, Valle M +14

Europe PMC2017
ArticleAyahuasca

The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.

Morales-García JA, de la Fuente Revenga M, Alonso-Gil S +4

Europe PMC2017
ArticleAyahuasca

Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.

Kuypers KP, Riba J, de la Fuente Revenga M +3

Europe PMC2016
ArticlePsilocybin

Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

Dos Santos RG, Osório FL, Crippa JA +3

Europe PMC2016
ArticlePsychedelics

Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans.

Maqueda AE, Valle M, Addy PH +11

Europe PMC2015
ArticleAyahuasca

Serotonergic psychedelics temporarily modify information transfer in humans.

Alonso JF, Romero S, Mañanas MÀ +1

Europe PMC2015